Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy.
Saved in:
| Title: | Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy. |
|---|---|
| Authors: | Eslami M; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Ermolaev N; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Kronberger C; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Schmid L; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Poledniczek M; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Gregshammer B; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Kösters A; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Alasti F; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Kammerlander AA; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Rettl R; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Duca F; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Binder C; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Kastner J; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Marculescu R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Badr Eslam R; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria. roza.badreslam@meduniwien.ac.at.; Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria. roza.badreslam@meduniwien.ac.at. |
| Source: | Scientific reports [Sci Rep] 2026 May 04. Date of Electronic Publication: 2026 May 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
